Commentary: What more do we need to know about medication-assisted treatment for prescripton opioid abusers?

Addiction

Volumn 104, Issue 5, 2009, Pages 784-785

  Magura, Stephen ^a  

^a WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

Buprenorphine treatment; Heroin; Methadone treatment; Prescription opioids; Treatment effectiveness; Treatment retention

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; METHADONE; NARCOTIC ANTAGONIST; PRESCRIPTION DRUG;

DRUG EFFICACY; HEROIN DEPENDENCE; METHADONE TREATMENT; NOTE; OPIATE ADDICTION; PRESCRIPTION; TREATMENT DURATION; HUMAN; PATIENT COMPLIANCE;

BUPRENORPHINE; HUMANS; MEDICATION ADHERENCE; METHADONE; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUGS;

EID: 64549140127     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2009.02581.x     Document Type: Note

References (6)

1. Banta-Green C. J., Maynard C., Koepsell T. D., Wells E. A., Donovan D. M. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction 2009 104 : 775 83.
2. Brands B., Blake J., Sproule B., Gourlay D., Busto U. Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug Alcohol Depend 2004 73 : 199 207.
3. Rosenblum A., Parrino M., Schnoll S. H., Fong C., Maxwell C., Cleland C. M. et al. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend 2007 9 : 64 71.
4. Hubbard R. L., Craddock S. G., Flynn P. M., Anderson J., Etheridge R. M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav 1997 11 : 261 78.
5. Magura S., Kang S. Y., Nwakeze P. C., Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse 1998 33 : 2441 67.
6. Magura S., Rosenblum A. Leaving methadone treatment: lessons learned, lessons forgotten, lessons ignored. Mt Sinai J Med 2001 68 : 62 74.